收费全文 | 6343篇 |
免费 | 540篇 |
国内免费 | 12篇 |
耳鼻咽喉 | 50篇 |
儿科学 | 131篇 |
妇产科学 | 81篇 |
基础医学 | 913篇 |
口腔科学 | 111篇 |
临床医学 | 862篇 |
内科学 | 1346篇 |
皮肤病学 | 134篇 |
神经病学 | 424篇 |
特种医学 | 220篇 |
外国民族医学 | 1篇 |
外科学 | 825篇 |
综合类 | 41篇 |
预防医学 | 589篇 |
眼科学 | 210篇 |
药学 | 507篇 |
中国医学 | 39篇 |
肿瘤学 | 411篇 |
2024年 | 8篇 |
2023年 | 93篇 |
2022年 | 210篇 |
2021年 | 394篇 |
2020年 | 216篇 |
2019年 | 256篇 |
2018年 | 227篇 |
2017年 | 181篇 |
2016年 | 198篇 |
2015年 | 198篇 |
2014年 | 248篇 |
2013年 | 275篇 |
2012年 | 455篇 |
2011年 | 455篇 |
2010年 | 237篇 |
2009年 | 240篇 |
2008年 | 385篇 |
2007年 | 401篇 |
2006年 | 326篇 |
2005年 | 310篇 |
2004年 | 256篇 |
2003年 | 213篇 |
2002年 | 159篇 |
2001年 | 146篇 |
2000年 | 130篇 |
1999年 | 113篇 |
1998年 | 48篇 |
1997年 | 45篇 |
1996年 | 26篇 |
1995年 | 23篇 |
1994年 | 26篇 |
1993年 | 21篇 |
1992年 | 58篇 |
1991年 | 40篇 |
1990年 | 27篇 |
1989年 | 57篇 |
1988年 | 24篇 |
1987年 | 32篇 |
1986年 | 23篇 |
1985年 | 24篇 |
1984年 | 11篇 |
1983年 | 14篇 |
1982年 | 7篇 |
1981年 | 13篇 |
1980年 | 5篇 |
1979年 | 11篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1975年 | 4篇 |
1974年 | 7篇 |
Background
Metastases to the brain occur in 10%-16% of patients with breast cancer, with incidence reportedly increasing. Historically, brain metastases (BM) have been treated with whole-brain radiation therapy (WBRT), but stereotactic radiosurgery (SRS) is an increasingly favored treatment option. In this study we used a population-level database to compare patterns of care and survival between WBRT and SRS for BM from breast cancer.Materials and Methods
The National Cancer Database was used to select patients treated with radiation for BM from primary breast cancer. Groups were classified on the basis of the modality of radiation delivered to the brain and compared across several demographic factors. A Kaplan–Meier survival curve and Cox multivariate analysis were used to compare overall survival. A matched analysis using propensity scores was used to further reduce confounders and compare survival.Results
The treatment groups were significantly different across several socioeconomic variables including income, insurance status, and treatment setting. The percentage of patients who received SRS increased dramatically in the second half of the analyzed time period (P < .001). Unadjusted median survival was significantly longer for patients who received SRS versus those who received WBRT (P < .001). This finding persisted after propensity score-matching.Conclusion
Receipt of SRS was associated with different socioeconomic variables and longer overall survival compared with WBRT, highlighting the need for less toxic treatment for patients who are now living longer. The results revealed important socioeconomic differences between patients selected for SRS versus WBRT and emphasizes disparities in access to modern radiation techniques across the United States. 相似文献Prosthetic joint infections (PJI) and especially tuberculosis (TB) PJI are rare diseases and hard to cure. The effectiveness of treatments for tuberculous PJI still remains a problem. The objective of this research was to indicate the success of two-stage revision replacement and also giving the associated criteria.
MethodsFrom 2015 to 2020, five patients with tuberculous PJI were treated with two-stage revision at Cho Ray hospital, Vietnam. We collected the dataset which included demographic data, the interval from the time of joint replacement to reported infection, records of tuberculous PJI, administration of anti-TB medications (duration, months), history of operation(s), duration of follow-up, and specific type(s) of antibiotics loaded in bone cement. The approval for this study was made by the institutional review board from Cho Ray Hospital, Vietnam. We conducted a literature review based on the keywords “PJI” and “TB” on PubMed.
ResultsFive patients [median age 66 years (range 35–84)] had found tuberculous PJI. The median time from arthroplasty to diagnosis was 19 months (range 4–48). The diagnosis was confirmed by joint aspirates or synovial tissue. Positive PCR was also reported in all cases. The average duration of anti-tuberculosis polytherapy administration was 14.4 months. The operative techniques on five patients included debridement and using spacer loaded with 2 g streptomycin (and 2 g vancomycin if they got a coinfection) for 1 pack of bone cement, and revision arthroplasty. In most cases, the outcome of treatment using two-stage revision replacement was 80%. Overall, the auxiliary bacterial infections were recognized in three patients with tuberculous PJI and Staphylococcus aureus. Streptomycin and vancomycin were loaded in a cement spacer to increase the success rate, and tuberculous PJI was controlled for all patients.
ConclusionTuberculous PJI can be controlled with two-stage revision replacement with an antibiotic-loaded cement spacer that is molded intraoperatively with custom mold and prolonged anti-tuberculosis treatment in all cases.
Level of evidenceIV.
相似文献Clinical/methodical issue
Entrapment syndromes of peripheral nerves at the elbow are common and are often diagnostically challenging disorders. Difficulties consist in lesion localization and recognition of complex spatial lesion patterns as well as in differentiation of focal and multifocal disorders.Standard diagnostic methods
Medical history taking, neurological examination and neurophysiological tests represent the gold standard in the diagnosis of peripheral nerve lesions at the elbow, but have known methodical limitations.Methodical innovations
Additional diagnostic imaging tools recently developed for high-resolution visualization of extended peripheral nerve segments include 3?T magnetic resonance neurography (MRN) and neurosonography.Performance
MRN and neurosonography can directly visualize and thus precisely localize focal and nonfocal peripheral nerve lesions of various origins with high spatial resolution at the anatomical level of nerve fascicles.Achievements
MRN can cover peripheral nerve structures at the elbow, evaluate spatial nerve lesion patterns and partly disclose underlying causes.Practical recommendations
Imaging of peripheral nerves is a valuable addition in the diagnostic work-up of entrapment syndromes at the elbow and provides important assistance in the differentiation of nonfocal differential diagnoses, especially in cases that cannot be clarified using standard diagnostic methods. The evaluation of spatial nerve lesion pattern may give additional information on the origin of the underlying disease, which is essential for further treatment.- The progressive motor neuronopathy (pmn) mouse is an autosomal recessive mutant, in which the homozygotes suffer caudio-cranial degeneration of motor axons and die several weeks after birth. This strain provides the opportunity of testing potential therapeutic strategies for the treatment of motor neurone diseases such as amyotrophic lateral sclerosis. We have performed a study of the effects on the pmn mouse of SR 57746A, an orally-active, non-peptide compound which has been found to exhibit neurotrophic effects in vitro and in vivo. In order to treat the affected mice from birth, the mothers were administered 2.5 mg kg−1, p.o., SR 57746A every two days until the weaning of the offspring (at day 20); then the offspring were given every two days a dose of 30 μg kg−1, p.o., until their death.
- Affected mice treated with SR 57746A had a lifespan 50% longer than that of the vehicle-treated mice (P=0.01). Compared to vehicle-treated pmn mice, SR 57746A improved the performance of the pmn mice in three different behavioural tasks. SR 57746A also maintained the amplitude of the motor evoked response of the gastrocnemius muscle, reduced the distal motor latency, and delayed the occurrence of the spontaneous denervation activity in this muscle. Histological studies indicated that at 20 days of age the mean surface areas of the fibres of the sciatic nerve were higher in SR 57746A-treated than in vehicle-treated mice.
- At present, SR 57746A is the only orally active, nonpeptide compound known to be capable of delaying the progression of the motor neurone degeneration in pmn mice.